Skip to main content
logo
Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
39.12
-1.34 (-3.31%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Celldex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,0721,8051,6772,1692,0991,803
Market Cap Growth
104.70%7.65%-22.71%3.32%16.42%160.10%
Enterprise Value
2,3591,2249241,9361,7791,383
Last Close Price
39.1227.1625.2739.6644.5738.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
19443.511168.13238.82315.12890.64387.68
PB Ratio
4.303.422.245.056.444.30
P/TBV Ratio
4.473.612.335.407.024.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14932.86792.34131.57281.34754.94297.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.010.010.010.01
Net Debt / Equity Ratio
-1.00-0.98-0.97-0.98-0.92-0.97
Net Debt / EBITDA Ratio
2.211.823.763.032.896.13
Net Debt / FCF Ratio
2.942.424.523.862.856.52
Asset Turnover
00.000.010.020.010.01
Quick Ratio
11.7110.2118.3813.6916.4124.71
Current Ratio
11.8210.4918.9213.8717.0724.86
Return on Equity (ROE)
-43.88%-40.62%-26.84%-37.45%-30.13%-22.43%
Return on Assets (ROA)
-27.62%-26.12%-19.38%-21.70%-16.79%-12.70%
Return on Capital Employed (ROCE)
-45.20%-54.00%-25.90%-32.70%-32.10%-16.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.78%-14.34%-9.42%-6.52%-5.35%-3.91%
FCF Yield
-7.88%-11.84%-9.53%-5.03%-5.03%-3.45%
Buyback Yield / Dilution
-4.49%-3.15%-32.91%-3.33%-9.37%-44.64%
SEC Filings: 10-K · 10-Q